ICCCImmuCellICCC info
$3.60info-2.96%24h
Global rank28365
Market cap$27.90M
Change 7d-4.26%
YTD Performance-26.98%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ImmuCell (ICCC) Stock Overview

    ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

    ICCC Stock Information

    Symbol
    ICCC
    Address
    56 Evergreen DrivePortland, ME 04103United States
    Founded
    -
    Trading hours
    -
    Website
    https://immucell.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    207 878 2770

    ImmuCell (ICCC) Price Chart

    -
    Value:-

    ImmuCell Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.60
    N/A
    Market Cap
    $27.90M
    N/A
    Shares Outstanding
    7.75M
    N/A
    Employees
    72.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org